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Cluster analysis of NDM-1 habouring isolates
Conclusion: This study documents the emergence of Acineto-
bacter spp. in the nosocomial environment and also the signiﬁcance
of different genospecies of Acinetobacter causing neonatal sep-
sis over an extended period of time. A unique assessment of the
diverse genetic determinants for carbapenemresistancewasnoted.
The emergence of NDM-1 among an already existing repertoire
of oxacillinases is a challenge for clinicians and microbiologists
alike. As new resistance mechanisms constantly evolve both lab-
oratory detection systems and infection control measures need to
be enhanced.
http://dx.doi.org/10.1016/j.ijid.2016.02.697
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Background: This study aimed to explore the prevalence rates
of Hospital Acquired Blood Stream Infections (HA-BSIs) by patients
and isolates during the deﬁned period in a tertiary care hospital,
Sultan Qaboos University Hospital (SQUH), in Oman.
Methods & Materials: Cross-sectional study during the period
from January 2013 to December 2013. Data about patients admit-
ted at the tertiary hospital were retrospectively collected during
the study period. The cumulative frequency and prevalence rates of
HA-BSIsbypatients and isolateswerecalculated. Inaddition, cumu-
lative frequency of participant with single versus mixed infections
and types of causative micro-organisms of HA-BSIs were obtained.
Results: Among the 30,764 patients analyzed, HA-BSIs occurred
in 268 patients, revealing a prevalence rate of 8.7 patients per 1000
admissions. Themajority of patientswithHA-BSIs hadmonomicro-
bial infection. The most common isolates were coagulase-negative
staphylococcus (21.4%), klebsiella pneuminae (12.3%), and candida
species (9.4%).
Conclusion: This study provides a benchmark for the epidemi-
ology of HA-BSIs in Oman. This rate is lower than rates reported by
most developing countries. Further reinforcement of infection pre-
vention and control measures are necessary to reduce these rates
further.
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Antibiotic prophylaxis for early ventilator
associated pneumonia in patients with stroke
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Background: Ventilator-associated pneumonia is one of the
most importantproblems in intensive careunits.Differentmethods
have been used so far to alleviate this problem. Administration of
prophylactic intravenous antibiotic is one of the methods that has
been used lesser. Piperacillin-tazobactam combination combines a
broad-spectrum penicillin and a beta-lactamase inhibitor. The aim
of this study is to prevent ventilator-associated pneumonia by the
combination of piperacillin-tazobactam.
Methods & Materials: In this clinical trial study, 84 patients
in intensive care unit entered the study. Patients were randomly
divided into two groups. Patients in the case group received
piperacillin 4 gr and tazobactam 0.5 gr in time of intubation and
also 12 hours later. The incidence of pneumonia and mortality rate
was recorded at the end of study.
Results: The incidence of early-onset pneumonia was 11.9% in
case and 33.3% in control group (p=0.011). The incidence of late-
onsetpneumoniawas42.8% in the case and50% in the control group
(p=0.084), although there was no statistically signiﬁcant difference
between the twogroups, but the incidenceof late-onsetpneumonia
was 7.2% lower than the control group. The mean duration of hos-
pitalization was signiﬁcantly greater in control group who did not
receive prophylactic antibiotics (p=0.026), while the difference in
lengthof stay in ICU (p=0.117) anddurationof ventilation (p=0.088)
was not signiﬁcant but the average length of time that the patients
in the case group were under mechanical ventilation was 8 days
lower than the control group and length of stay in the intensive
care unit in the case group was 9 days less compared the control
group that is economically important. Finally at the end of ﬁrst
week 4 patients (9.5%) in the case group and 9 patients (21.4%) in
the control group died (p=0.131).
Conclusion: Using prophylactic piperacillin-tazobactam could
signiﬁcantly decrease early-onset pneumonia. Despite the fact that
this combination could reduce the incidence of late-onset pneumo-
nia andmortality in the intervention group compared to the control
group, but this difference was not signiﬁcant. It seems that this
combination can be used to decrease early ventilator-associated
pneumonia and reduces hospital and ICU length of stay.
http://dx.doi.org/10.1016/j.ijid.2016.02.699
